PMV Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
PMVP Nasdaq 2834 www.pmvpharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for PMV Pharmaceuticals, Inc.

These Biotech Stocks Are Cheap Based On 1 Fundamental Measure - Sep 17th, 2026 3:34 pm
Should You Buy PMV Pharmaceuticals, Inc. (PMVP) After Golden Cross? - Sep 16th, 2026 7:55 am
PMV Pharmaceuticals Appoints Philip Herman as Chief Commercial Officer - Sep 8th, 2026 6:00 am
PMV Pharma Raises $50.8 Million to Fuel Cancer Drug Push - Sep 1st, 2026 7:01 am
PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities - Aug 31st, 2026 9:03 pm
PMV Pharmaceuticals Reports Updated Rezatapopt Ovarian Cancer Data, Commences Offering - Aug 31st, 2026 2:50 pm
PMV Pharma Announces Proposed Public Offering of Securities - Aug 31st, 2026 2:02 pm
PMV Pharmaceuticals Announces Updated Promising Rezatapopt Monotherapy Interim Ovarian Cancer Data From PYNNACLE Phase 2 Pivotal Trial - Aug 31st, 2026 2:01 pm
PMV Pharmaceuticals (PMVP) Upgraded to Buy: What Does It Mean for the Stock? - Aug 19th, 2026 10:00 am
PMV Pharmaceuticals Reports Second Quarter 2026 Financial Results and Corporate Highlights - Aug 14th, 2026 6:00 am
PMV Pharmaceuticals (PMVP) Upgraded to Buy: Here's Why - Jun 24th, 2026 10:00 am
PMV Pharmaceuticals (PMVP) Loses 26% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Jun 10th, 2026 7:35 am
Why PMV Pharmaceuticals, Inc. (PMVP) Faces Funding Concerns Despite Positive Trial Activity - Jun 2nd, 2026 7:56 am
12 Health Care Stocks Moving In Wednesday's After-Market Session - May 13th, 2026 3:06 pm
PMV Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Highlights - May 12th, 2026 6:00 am
PMV Pharmaceuticals Announces Board Chair Transition - Apr 22nd, 2026 6:00 am
Is PMV Pharmaceuticals (NASDAQ:PMVP) In A Good Position To Invest In Growth? - Apr 20th, 2026 12:34 pm
New England Journal of Medicine Publishes First-in-Human Rezatapopt Data Showing Selective Reactivation of Mutant p53 in Advanced Solid Tumors - Feb 26th, 2026 6:00 am
CarMax Stock Down 47% This Past Year, But One Fund Is Betting $6 Million on a Turnaround - Feb 3rd, 2026 8:20 am